Skip to main content
Have a personal or library account? Click to login
Sunitinib and Reversible Posterior Leukoencephalopathy Syndrome: the usual suspect but not always the culprit. A case report. Cover

Sunitinib and Reversible Posterior Leukoencephalopathy Syndrome: the usual suspect but not always the culprit. A case report.

Open Access
|Apr 2025

Figures & Tables

Figure 1:

Brain MRI showed bilateral high intensity lesions in the white matter of the occipital, parietal and cerebellar lobes, and dorsal brainstem [Fig. 1A], supporting a diagnosis of Reversible Posterior Leukoencephalopathy Syndrome. One month following admission there was complete resolution [Fig. 1B].

DOI: https://doi.org/10.2478/fco-2024-0002 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 14 - 18
Submitted on: Jul 17, 2024
Accepted on: Nov 13, 2024
Published on: Apr 15, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services

© 2025 Ourania Katopodis, Maria Lerikou, Georgios Karagiorgis, Spyridon Arvanitakis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.